<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">Since it emerged in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to all parts of the world, infecting more than 5 million people and directly causing more than 340 000 deaths.
 <xref rid="bib1" ref-type="bibr">
  <sup>1</sup>
 </xref> Coronavirus disease 2019 (COVID-19), the disease caused by SARS-CoV-2, was initially viewed as primarily a respiratory disease, in some cases leading to a viral pneumonia. It is now recognised as a complex disorder affecting many body systems, which, especially in older males, can require treatment in ICUs. Amongst those admitted to intensive care, a substantial proportion will die. This new disease has generated a surge of research, with more than 4000 papers published in 1 week in May 2020.
 <xref rid="bib2" ref-type="bibr">
  <sup>2</sup>
 </xref> Here, we attempt to summarise emerging evidence for anaesthetists and intensive care specialists caring for patients with COVID-19.
</p>
